SARS-CoV-2 (COVID-19) Clinical Trial 20213042
[LCID Study Number: 20213042]
Compassionate Use of REGN-COV2 for the Treatment of COVID-19
The purpose of this study is to provide Compassionate Use access to REGN-COV2 for adult patients with recently diagnosed mild-to-moderate coronavirus disease (COVID-19) who are at high risk for poor outcomes.
Disease/Condition: SARS-CoV-2 (COVID-19)
Department: Pulmonary and Critical Care
Location(s): Lahey Hospital & Medical Center (Burlington)
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-2734